GlassScriptPhysician profile
Kyle P Martin
NPI 1851308258
$5,474.30
in general payments reported to CMS, 2019-2025
40 companies · $795 in 2025
The $795 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $447 · 2020: $370 · 2021: $837 · 2022: $1,417 · 2023: $691 · 2024: $918 · 2025: $795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,403.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $589.38 | 2019-2024 | |
| Pfizer INC. | $483.32 | 2020-2025 | |
| Biogen, INC. | $379.56 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $310.88 | 2019-2025 | Slynd |
| Daiichi Sankyo INC. | $295.13 | 2019-2025 | Injectafer |
| Intuitive Surgical, INC. | $289.40 | 2022 | |
| Mayne Pharma Commercial LLC | $289.04 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $265.77 | 2019-2023 | Trintellix |
| Shield Therapeutics INC | $259.91 | 2022-2025 | Accrufer |
| Sumitomo Pharma America, INC. | $233.42 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $208.11 | 2022-2025 | Novasure, Omni Hysteroscope, Myosure Tissue Removal Device |
| Astellas Pharma US INC | $206.62 | 2019-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $130.22 | 2020-2025 | |
| Myovant Sciences INC. | $124.07 | 2022 | |
| Aspira Women'S Health INC | $117.47 | 2022-2023 | Ova1 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $114.83 | 2019-2022 | |
| Bausch Health US, LLC | $110.04 | 2019-2021 | |
| Mylan Pharmaceuticals INC. | $102.42 | 2019-2022 | |
| Organon LLC | $100.47 | 2024-2025 | Nexplanon |
| Avion Pharmaceuticals | $96.96 | 2019-2022 | |
| Millicent US INC | $91.14 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Scynexis, INC. | $90.26 | 2022 | |
| Caldera Medical, INC | $75.71 | 2021 | |
| Agile Therapeutics, INC. | $72.05 | 2021-2024 | Twirla |
| Coopersurgical, INC. | $51.32 | 2022-2024 | Paragard T 380a, Paragard T 380a |
| Duchesnay USA Incorporated | $43.92 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $43.36 | 2024 | Exparel |
| Novo Nordisk INC | $39.05 | 2021-2022 | |
| Medtronic, INC. | $33.90 | 2024-2025 | Interstim, Truclear |
| Monaghan Medical Corporation | $31.88 | 2024 | Aeroeclipse |
| Virtus Pharmaceuticals LLC | $28.30 | 2021 | |
| Evofem Biosciences, INC. | $23.69 | 2021 | |
| Northgate Technologies, INC. | $23.22 | 2024 | Stimsite |
| Optumhealth Care Solutions, LLC | $22.71 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Davol INC. | $22.57 | 2023 | Arista Ah Flexitip |
| Axonics, INC. | $17.35 | 2024 | Bulkamid |
| Merck Sharp & Dohme LLC | $15.30 | 2022 | |
| Dermira, INC. | $14.94 | 2020 | |
| Hologic INC | $13.40 | 2021 | |
| Lupin INC. | $13.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.